US WorldMeds: Walgreens (WBA) to Stock LUCEMYRA Across US With New Pact
Walgreens' (WBA) agreement with US WorldMeds finalized as recent report outlines a surge of 30% in drug overdose deaths in 2020.
Read full article »
Founder & CEO
Paul Breckinridge Jones
US WorldMeds is a pharmaceutical company that develops and commercializes therapies for the treatment of idiopathic parkinson's disease.
Read more